RF
VC

Retinal Degeneration Fund

Retinal Degeneration Fund is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Ophthalmology and Medical Devices, 4 tracked investments.

4
Investments Tracked

About Retinal Degeneration Fund

Operating out of the United States, Retinal Degeneration Fund is a venture capital firm. Our dataset covers 4 investments involving Retinal Degeneration Fund.

Recorded deals span Healthcare & Life Sciences, Ophthalmology, Medical Devices and Medical Network. Coverage extends to 8 sectors in total. Participation spans Series B and Series C+ rounds.

The Gund Vision Fund invests primarily in clinical-stage or near clinical-stage companies advancing therapeutics for inherited retinal diseases and dry age-related macular degeneration. It uses equity, convertible debt, royalties, and project-based co-funding, deploying capital globally with initial investments of $1 to $5 million, and follow-on reserves up to $10 to $15 million.

Investment Focus

Stage Focus
series-bseries-c-plus
Sectors
Healthcare & Life Sciencesophthalmologymedical devicesmedical networkpharmaceutical-developmentcardiologytherapeuticsr-d

Investment Thesis

The Gund Vision Fund invests primarily in clinical-stage or near clinical-stage companies advancing therapeutics for inherited retinal diseases and dry age-related macular degeneration. It uses equity, convertible debt, royalties, and project-based co-funding, deploying capital globally with initial investments of $1 to $5 million, and follow-on reserves up to $10 to $15 million.

Team

Rusty Kelley, PhD, MBAManaging Director, Gund Vision Fund
Alicia Kemble, PhDPrincipal, Gund Vision Fund
Grace WarnerVenture Analyst, Gund Vision Fund

Explore Retinal Degeneration Fund's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Ophthalmology